A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions
Clinical trial NCT07421401 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07421401
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-13
- Primary completion
- 2026-06-11
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.